Does JAKAVI Cause Myelofibrosis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Myelofibrosis have been filed in association with JAKAVI. This represents 4.7% of all adverse event reports for JAKAVI.
7
Reports of Myelofibrosis with JAKAVI
4.7%
of all JAKAVI reports
3
Deaths
0
Hospitalizations
How Dangerous Is Myelofibrosis From JAKAVI?
Of the 7 reports, 3 (42.9%) resulted in death.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for JAKAVI. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does JAKAVI Cause?
Death (30)
Platelet count decreased (22)
Anaemia (17)
Splenomegaly (16)
Haemoglobin decreased (13)
Cardiac failure (9)
Dyspnoea (9)
Thrombocytopenia (9)
Pyrexia (8)
Fatigue (7)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
Which JAKAVI Alternatives Have Lower Myelofibrosis Risk?
JAKAVI vs KETAMINE
JAKAVI vs KETOCONAZOLE
JAKAVI vs KETOPROFEN
JAKAVI vs KETOROLAC TROMETHAMINE
JAKAVI vs LABETALOL\LABETALOL